albendazole has been researched along with Retrolental Fibroplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pourgholami, MH | 1 |
| Khachigian, LM | 1 |
| Fahmy, RG | 1 |
| Badar, S | 1 |
| Wang, L | 1 |
| Chu, SW | 1 |
| Morris, DL | 1 |
1 other study available for albendazole and Retrolental Fibroplasia
| Article | Year |
|---|---|
Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis.
Topics: Albendazole; Angiogenesis Inhibitors; Animals; Capillary Permeability; Cell Movement; Cells, Culture | 2010 |